• Filter By:
  • Levofloxacin 1.5% approved

  • Primary Care Optometry News, April 2004
  • OSAKA, Japan — U.S. regulators have approved levofloxacin ophthalmic solution 1.5% (Iquix, Santen) for the treatment of both gram-positive and...More »
  • Bisphosphonates can have ocular side effects

  • Primary Care Optometry News, November 2003
    Michael J. Trad, OD
  • The class of systemic medications known as bisphosphonates is used to increase bone density in patients with osteoporosis, myeloma bone disease, Paget’s...More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

[X]